MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Revenue
$730,571
Net Income
-$2,752,681
Net Profit Margin
-376.78%
EPS
-$0.26
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
Revenues
730,571
353,375
511,283.25*
Cost of revenues
425,844
290,491
360,148*
Gross profit
304,727
62,884
151,135.25*
Sales, general and administrative
1,291,318
1,352,758
835,710.75*
Research and development
257,632
153,482
148,142.25*
Total operating expenses
1,548,950
1,506,240
983,853*
Operating loss
-1,244,223
-1,443,356
-832,717.75*
Interest expense
272,245
267,008
39,051.75*
Interest income
14,476
6,653
5,349.75*
Loss on change in fair value of warrant liability
-
-148,766
1,934.25*
Loss on issuance of convertible note
-4,236
-322,359
-70,191*
Other expense, net
-115
-
-28.75*
Total other (expense) income
-262,120
-731,480
-101,987.5*
Net loss
-1,506,343
-2,174,836
-934,705.25
Deemed dividend on warrant modifications
1,124,676
-
-
Preferred stock dividends
121,662
-54,192
-
Net loss attributable to common stockholders
-2,752,681
-2,120,644
-
Basic EPS
-0.26
-0.28
-0.19
Diluted EPS
-0.26
-0.28
-0.19
Basic Average Shares
10,790,722
7,657,229
4,930,287
Diluted Average Shares
10,790,722
7,657,229
4,930,287
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

AIDX Income Statement Sankey DiagramSankey diagram visualizing AIDX income statement for the periodNet lossattributable to common...-$2,752,681 Net loss-$1,506,343 Deemed dividend onwarrant modifications$1,124,676 Preferred stock dividends$121,662 Revenues$730,571 Operating loss-$1,244,223 Total other (expense)income-$262,120 Gross profit$304,727 Interest income$14,476 Cost of revenues$425,844 Total operatingexpenses$1,548,950 Interest expense$272,245 Loss on issuance ofconvertible note-$4,236 Other expense, net-$115 Sales, general andadministrative$1,291,318 Research and development$257,632

20 20 Biolabs, Inc. (AIDX)

20 20 Biolabs, Inc. (AIDX)